SEC bars ex-Goldman trader from industry in mortgage securities fraud case
- Top 10 News for 12/2: Crude Rips on OPEC Cut; Starbucks' Schultz Steps Down; Nonfarm Payrolls Flat in Nov.
- Unemployment Rate Drops to 4.6%
- Bond yields slip on U.S. jobs data, euro steady before Italy vote
- Alibaba (BABA) Founder Jack Ma Discuss Plans to Retire; 'I Don't Want to Die at the Office'
- Starbucks Coffee (SBUX) CEO Howard Schultz to Step Down, Appointed Executive Chairman; Kevin Johnson New CEO
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.
By Suzanne Barlyn
(Reuters) - A former head mortgage trader for Goldman Sachs Group Inc has agreed to be barred from the securities industry and pay $400,000 to settle charges that he repeatedly mislead customers, causing them to pay higher prices, a U.S. regulator said on Tuesday.
Edwin Chin, Goldman's former head trader for residential mortgage-backed securities, generated extra revenue for the company by concealing the prices at which it had bought such mortgages, the U.S. Securities and Exchange Commission said in a statement.
Chin then resold the mortgages at higher prices to customers while Goldman pocketed the difference, the agency said. His conduct began in 2010 and continued until he left Goldman in 2012.
The SEC said Chin also misled buyers by suggesting he was negotiating transactions between customers when he was merely selling the mortgages from Goldman’s inventory.
Chin neither admitted to nor denied the findings, the SEC said.
A lawyer for Chin could not be immediately reached for comment.
Goldman terminated Chin in 2012, a spokesman said.
(Reporting by Suzanne Barlyn; Editing by Lisa Von Ahn)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Caterpillar (CAT) Offers FY17 Guidance Update at Credit Suisse Conference
- WildHorse Resource Development (WRD) Launches 27.5M Common Stock IPO
- Axsome Therapeutics (AXSM) Files $200M Mixed Securities Shelf
Create E-mail Alert Related CategoriesReuters
Related EntitiesGoldman Sachs
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!